[Drug-coated stents. Where do we stand in 2004?].
Scheller
B
B
D015906:Angioplasty, Balloon, Coronary / Q000295:instrumentation*; D000818:Animals; D020099:Coated Materials, Biocompatible; D023903:Coronary Restenosis / Q000517:prevention & control*; D003920:Diabetes Mellitus; D016503:Drug Delivery Systems; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D017239:Paclitaxel / Q000008:administration & dosage; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D020123:Sirolimus / Q000008:administration & dosage; D015607:Stents / Q000009:adverse effects
D020099:Coated Materials, Biocompatible; D007166:Immunosuppressive Agents; D017239:Paclitaxel; D020123:Sirolimus
Medikamentenbeschichtete Stents. Wo stehen wir 2004?